Cellular Origins Completes Series A Financing Round — The Pharma Navigator - Navigating The Key News Stories In Pharma

▤ Summary

Cellular Origins raised $40 million in a Series A round led by Johnson & Johnson Innovation, with participation from Highland Europe, BGF, NYBC Ventures, and TTP Group. The company will use the capital to expand its commercial team, accelerate development of its Constellation robotic platform, and broaden the unit operations it supports. It also plans to build the systems and infrastructure needed for manufacturing and services scale-up. The company says the investment will help it deliver scalable, automated cell therapy manufacturing and prepare for broader advanced therapies use cases.

$ Funding

▦ Linked Companies